Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions